jrf30
2 semanas hace
Analyst price adjustment. FYI.
"B. Riley Securities, Inc. Raises Price Target from $3.00 to $5.00 on UAMY"
I won't be part of it. I bought expecting this thing to go from $1 to maybe $2.50. Since I don't buy on hype, but try to buy on fundamentals, that would be huge for me. Then, I kept adding on the way up, until I had a LOT of shares. At $3.40, I think it has overstepped it's target. Might be wrong, and hope for all longs I am, but sold rest this morning. That's what my M L U was on last post. "More lightening Up" by me. Went further, and sold out the rest. Can buy a small house with the profit from this alone, so VERY happy with it.
Moving on. Wishing longs the best.
jrf30
1 mes hace
The CEO was asked that same question on the call. If you can find it, it is worth listening to.
He said his goal is to be a one billion dollar company, just like his last ones he managed, and that he felt very comfortable saying it will be reached. Why so? Because he is ramping up huge revenue increases and positive net earnings, so he feels the stock will respond well past that level. We'll have to see what happens, but it's nice to have a CEO who is sure it will happen AND has done it before.
jrf30
1 mes hace
This thing moves fast. I decided to look at some of my buys in the past and it showed me more than I expected. I share so you can SEE how much this baby is moving, and how much it CAN move from here.
My first buy was on 12/2 at $0.7758. Missed the $0.65 I was trying ot buy, and then went in at market to not chase it as it went higher. HA!!! Chased it anyway, and GLAD I did. Same day I bought more shares at $0.8003. Odd fill numbers, but it was trading pretty thin then. NEXT DAY I bought at $0.9997. Yep, that's in one day. SO big mover. Two days later, 12/5, I bought at $1.1889. UP from $0.7758 on 12/2. STEADY upward and pretty nicely to boot. I bought more through December, and my first buy in 2025 was on January 6th. Paid $1.8479. Showing even with the stock up over 100%, I was still a BUYER. This is not just some short term flash in the pan, or a one week wonder. Since then??? Well, my LATEST (not necessarily my last) buy was March 24th, at $2.0093 in one account and $2.01 in another. I'm still a buyer. Oh, plus I wrote the $1.50 puts that expired on March 21 and have more puts short that expire 4/17/25. Extra income, and if for some odd reason it went down to $1.50, I'd GLADLY buy more. I don't think we are going to see that price again.
I say all that to say 1) I'm still bullish. 2) it has been moving for about 3 MONTHS now, so not some fly by night pump and dump by a group that comes on the board, posts a lot, and then sells and it drops again after a week or two weeks, and 3) the story is MORE compelling now than it was in December. Back then, it was a buy because China stopped selling Antimony to the USA. Now? Now they have new contracts in place, they decided to reopen their closed mill in MX, the price has continued up, revenues are already up and about to go haywire, and profitability has been mentioned by management as in the near future. Things that have me still adding, averaging UP, and still saying this is a good buy. IMHO, of course.
jrf30
1 mes hace
ANalyst review of UAMY
United States Antimony Corp. (UAMY)
UAMY: Price: $1.79; Market Cap (M): $202
Rating: Buy; Price Target: $2.60
Heiko F. Ihle, CFA
4Q24 and 2024 Financial Results; Surging Antimony Price Drives Revenue Growth; 2025 Guidance; Reit. Buy; PT Up to $2.60
Click here for complete report and disclosures
On March 20, United States Antimony (UAMY) released its 2024 financial results. During the year, the company recorded $14.9M in revenue, which yielded a net loss of $1.7M, or ($0.02) per share. This compares to 2023 revenue of $8.7M, which yielded a net loss of $6.3M, or ($0.06) per share. Revenue mostly reached our estimate of $15.2M for the year. We note that the 72% YoY revenue increase was driven by the significant growth in the price of antimony following China’s recent export ban. In our view, UAMY should maintain an opportunity to record significant revenue amid strong margins in the coming quarters if worldwide antimony supply from geopolitically safe jurisdictions remains below supply. We also emphasize recent margin improvements, as revenue costs decreased about 5% YoY. Finally, we reiterate our view that UAMY remains well-positioned to invest in its operations and generate significant free cash flow given its cash and cash equivalents balance of $18.2M.
4Q24 financial results. During the quarter, UAMY recorded $6.9M in revenue. 4Q24 revenue came in right around our estimate of $7.1M. The firm ultimately incurred a (largely irrelevant) net loss of $1.1M, or ($0.01) per share. In our view, strong performance during the quarter further showcases UAMY's potential over the coming periods, especially with antimony prices surging in December 2024 after China’s export ban. We anticipate this effect to be felt much more in 2025, since this sharp impact to pricing was just before quarter-end. In contrast, we note ongoing increases to UAMY's cost base as management expands the scope of its operations aggressively. Overall, however, we expect UAMY's recognition of significant revenue to meaningfully benefit and significantly outweigh new expenditures of its growing business.
2025 outlook and near-term plans. Management now expects to reach 2025 revenue of $35.0M - $50.0M, which is right around our prior estimate of $40.0M. We stress that our production forecast is likely in-line with actual production though our estimated pricing may ultimately prove to be conservative. The company is restarting operations at its Madero Smelter in Mexico, with new antimony material and raw antimony inventory expected to arrive at site in the near-term. In addition, we highlight that the necessary improvements to furnaces at Madero have been completed and that the site is likely to further improve UAMY’s production and financial performance during 2025.
We reiterate our Buy rating on UAMY and increase our PT to $2.60 from $2.50. The slight increase to our PT was driven by rolling our DCF forward one year, while also accounting for the company's updated balance sheet. Our valuation for the firm remains based on our DCF of antimony and zeolite operations. We maintain our 12.0% and 15.0% discount rates for these businesses, respectively. We value the company’s current operations at $312.4M, in addition to a fixed value of $10.0M that we assign to UAMY's Mexican assets and mining claims in Alaska and Ontario. We then add about $18.2M in cash and cash equivalents before subtracting outstanding debt, ultimately giving the firm a total value of $340.0M, or $2.59 per share. We then round this figure to our final PT of $2.60.
Near-term catalysts. Looking ahead, we plan to monitor UAMY’s continued expansion of production during a geopolitically challenged time. We reiterate that our revenue estimate may ultimately prove to be conservative given current spot pricing amid strong demand. We also highlight that the company’s mining claims in Alaska and Ontario seem to be mostly ignored by the market even as they provide the firm with greater exposure to critical minerals such as cobalt, nickel, copper, and bismuth. Management noted the ongoing turnaround of its firm’s zeolite division, with plant uptime at the site increasing to 98.4% from below 50.0%. The firm has already hired dedicated sales personnel following year-end. In short, we expect to see improvements in revenue and margins for UAMY’s zeolite business going forward, which should ultimately further improve the company’s financial position.
Risks. (1) Commodity price risk; (2) operational and technical risk; (3) liquidity risk; and (4) political risk.
Heiko F. Ihle, CFA
212-356-0510
hihle@hcwresearch.com
jrf30
1 mes hace
Awesome call just now. Looking to go to Russell 2000 in a few months, adding institutional investors now, demand is growing, revenue up to $14MM and expected about $40MM in 2025, and firing on all cylinders. Looking for more positive movement over the next few months. Oh, and with a market cap of about $195MM, he was asked if it can get to $1B. He not only said yes, but it is basically just a stop on the way for him, and he has done it with every other company he has managed. That's 500% or more above today's price. yea - a good call.
jrf30
4 meses hace
I'm amazed the board is still so quiet, even with such a rise. For me, from $0.7758 as my first buy on 12/2 to $2.10 today on 12/16, a mere two weeks!! My average cost basis is much higher, at $1.02 because I kept buying up to about $1.25, but still up over 100% in two weeks. Merry Christmas. Anyway, glad to be on board, wrote the $2.50 calls for extra income, and holding for now. See if they get called away from me. If not, that is another nice gain from the stock. Amazed we are still so dead over here!
jrf30
4 meses hace
news for tomorrow
We would like to inform our shareholders and investors that the Chairman and CEO of U.S. Antimony Corporation (NYSE: UAMY), Mr. Gary C. Evans, is being featured tomorrow on Fox Business with Maria Bartiromo at 8:30am Eastern Time, Friday, December 13, 2024.
Viewers can tune in live on FOX Business or visit www.foxbusiness.com for details on the segment.
About United States Antimony Corporation
United States Antimony Corporation (NYSE: UAMY) is a leader in the production and refinement of antimony and zeolite, with a focus on supporting critical industries such as defense, technology, and clean energy. As the only antimony smelter in North America, the company plays a pivotal role in ensuring domestic access to this critical mineral, which is essential for national security and modern manufacturing.
For more information, please visit www.usantimony.com.
jrf30
4 meses hace
More news.
On December 10, 2024, MCMANUS MICHAEL A JR, a Director at United States Antimony Corp (UAMY, Financial), purchased 70,000 shares of the company. Following this transaction, the insider now owns a total of 338,333 shares. This purchase is part of a broader trend, as over the past year, the insider has acquired a total of 255,000 shares and has not sold any shares. United States Antimony Corp is engaged in the production and sale of antimony, silver, gold, and zeolite products. The company operates through its subsidiaries and is involved in mining, milling, and smelting operations. The insider transaction history for United States Antimony Corp indicates a positive trend, with 5 insider buys and 0 insider sells over the past year.
Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
BIOCHEMUP
4 días hace
Monksdream
2 semanas hace
glenn1919
4 meses hace
Limey42
5 meses hace
MrT73
5 meses hace
MWM
5 meses hace
cybersync
11 meses hace
81vette
2 años hace
Hot Features
Premium
